Nalaganje...
Indirect Regulation and Equilibrium of p35 and p40 Subunits of Interleukin (IL)-12/23 by Ustekinumab in Psoriasis Treatment
BACKGROUND: Ustekinumab, a human-derived monoclonal antibody that targets the p40 subunit of interleukin (IL)-12 and IL-23, has excellent clinical efficacy and safety in treating psoriasis, with a long half-life. However, no reports have described the use of human skin/serum samples to elucidate its...
Shranjeno v:
| izdano v: | Med Sci Monit |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
International Scientific Literature, Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977627/ https://ncbi.nlm.nih.gov/pubmed/31910201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.920371 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|